Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade

被引:15
|
作者
Vogel, Isabel [1 ]
Verbinnen, Bert [1 ]
Van Gool, Stefaan [1 ,2 ,3 ]
Ceuppens, Jan L. [1 ]
机构
[1] KULeuven, Clin Immunol Lab, Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium
[2] KULeuven, Childhood Immunol, Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium
[3] Immunol Onkol Zentrum Koln, Cologne, Germany
来源
JOURNAL OF IMMUNOLOGY | 2016年 / 197卷 / 02期
关键词
VERSUS-HOST-DISEASE; ALLOGRAFT-REJECTION; TOLERANCE; INDUCTION; LIGAND; CD40; CD4(+)CD25(+); ACTIVATION; CTLA4-IG; TRANSPLANTATION;
D O I
10.4049/jimmunol.1502039
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Blocking of costimulatory CD28/B7 and CD40/CD40L interactions is an experimental approach to immune suppression and tolerance induction. We previously reported that administration of a combination of CTLA-4Ig and MR1 (anti-CD40L mAb) for blockade of these interactions induces tolerance in a fully mismatched allogeneic splenocyte transfer model in mice. We now used this model to study whether regulatory T cells (Tregs) contribute to immune suppression and why both pathways have to be blocked simultaneously. Mice were injected with allogeneic splenocytes, CD4(+) T cells, or CD8(+) T cells and treated with MR1 mAb and different doses of CTLA-4Ig. The graft-versus-host reaction of CD4(+) T cells, but not of CD8(+) T cells, was inhibited by MR1. CTLA-4Ig was needed to cover CD8(+) T cells but had only a weak effect on CD4(+) T cells. Consequently, only the combination provided full protection when splenocytes were transferred. Importantly, MR1 and low-dose CTLA-4Ig treatment resulted in a relative increase in Tregs, and immune suppressive efficacy was abolished in the absence of Tregs. High-dose CTLA-4Ig treatment, in contrast, prevented Treg expansion and activity, and in combination with MR1 completely inhibited CD4(+) and CD8(+) T cell activation in a Treg-independent manner. In conclusion, MR1 and CTLA-4Ig act synergistically as they target different T cell populations. The contribution of Tregs to immune suppression by costimulation blockade depends on the concentration of CTLA-4Ig and thus on the degree of available CD28 costimulation.
引用
收藏
页码:533 / 540
页数:8
相关论文
共 50 条
  • [1] CD28/CTLA-4/B7 and CD40/CD40L costimulation and activation of regulatory T cells
    Isabel T Vogel
    Stefaan W Van Gool
    Jan L Ceuppens
    World Journal of Immunology, 2014, 4 (02) : 63 - 77
  • [2] Synergistic effect of CD40L/CD40 and CD28/B7 blockade in murine EAE
    Schaub, M
    Chandraker, A
    Sayegh, MH
    Khoury, SJ
    NEUROLOGY, 1997, 48 (03) : 6067 - 6067
  • [3] Synergistic effect of CD40L/CD40 and CD28/B7 blockade in murine EAE.
    Schaub, M
    Chandraker, A
    Stadlbauer, T
    Sayegh, MH
    Khoury, SJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 834 - 834
  • [4] Locally produced complements are mediators of B7•CD28 and CD40• CD40L costimulation during cognate APC•T cell interactions
    Strainic, Michael G.
    Lalli, Peter
    Liu, Jinbo
    Heeger, Peter S.
    Medof, M. Edward
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 245 - 245
  • [5] Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection
    Subbotin, V
    Sun, H
    Chen, C
    Aitouche, A
    Valdivia, L
    Fung, JJ
    Starzl, TE
    Rao, AS
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 941 - 942
  • [6] Costimulation Blockade of CD40 and CD28 Pathways in Limb Transplantation
    Tung, T. H. H.
    Mackinnon, S. E.
    Mohanakurnar, T.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (10) : 3723 - 3724
  • [7] CD28:CTLA-4/B7及CD40/CD40L与多发性硬化
    唐玉兰
    郑金瓯
    医学综述, 2008, (02) : 164 - 166
  • [8] Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4+ T cells
    Steven C. Eck
    Laurence A. Turka
    Cancer Immunology, Immunotherapy, 1999, 48 : 336 - 341
  • [9] Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4+ T cells
    Eck, SC
    Turka, LA
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (06) : 336 - 341
  • [10] B7/CD28-DEPENDENT AND B7/CD28-INDEPENDENT INDUCTION OF CD40 LIGAND EXPRESSION
    DING, L
    GREEN, JM
    THOMPSON, CB
    SHEVACH, EM
    JOURNAL OF IMMUNOLOGY, 1995, 155 (11): : 5124 - 5132